Please login to the form below

Not currently logged in
Email:
Password:

Hanover Brussels appoints Aurélie Marchand as account director

She joins the communications consultancy from Hill & Knowlton Strategies Paris

Aurelie MarchlandHanover Brussels has bolstered its policy team with a new senior hire in the form of Aurélie Marchand, who joins the communications and public affairs consultancy as its EU health account director.

She joins the group from Hill & Knowlton Strategies Paris, where she spent the past six years as its public affairs lead advising healthcare and FMCG clients.

Marchand said: “I am extremely honoured to join such a renowned and forward-thinking agency.

“Coming from a country where market access and negotiations around pricing and reimbursement can be challenging, I’m eager to bring this experience to the EU level.”

Prior to Hill & Knowlton, Marchand served Sanofi, where she worked on French Parliament relations and she has held several positions within the French administration working for general secretariat for European affairs and the Ministry of Immigration.

Emma Eatwell, director of EU healthcare, Hanover, said: “With her [Marchand] wealth of experience at both national and European level, she will be an excellent addition to our team and will be instrumental in continuing the growth of our business.”

In her new role, Marchand will report to Eatwell and she will oversee the group’s portfolio of clients, which includes Sanofi Pasteur and Vertex Pharmaceuticals.

19th November 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
TRIDUCIVE

Hello we’re Triducive. We’re a healthcare strategy and value consultancy that provides expert and insight-driven solutions that strengthen and realise...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics